14 February 2011
PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies (PanCareSurFup)
Major EU project to tackle complications of cancer treatment in childhood and adolescence
Survival of patients affected by cancer in childhood and adolescence has improved substantially, such that up to 80% of these patients survive 5 years after their diagnosis. However, the treatments leading to these favourable results often lead to variable long-term side-effects in the survivors, including physical disability, cardiovascular or kidney insufficiency, hormone imbalances affecting fertility or cognitive function, and others.
Read more
Geographic variation of mutagenic exposures in kidney cancer genomes
Scientists from the International Agency for Research on Cancer (IARC) and partner institutions h...
02.05.2024
Read more
IARC Monographs Volume 134: Aspartame monograph now available
The monograph on aspartame, the first monograph in IARC Monographs Volume 134: Aspartame, Methyle...
29.04.2024
Read more
Launch of CanScreen5 training in francophone African countries
The International Agency for Research on Cancer (IARC) is pleased to announce the launch of the C...
29.04.2024
Read more